Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Aarti Drugs has informed that the officials of the Company will be attending the Investor Conference on September 22, 2021 with Phillip Capital (India). The copy of Investor Presentation-June 2021 to be shared with participants has already been uploaded on stock exchanges and is also available on the website of the Company at www.aartidrugs.co.in. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. The changes may happen due to exigencies on the part of Host/ Company.
The above information is a part of company’s filings submitted to BSE.
